Integration of a Psilocybin Experience in a 45-Year-Old Veteran

The client, a 45-year-old male combat veteran with treatment-resistant PTSD (17-year duration, failed SSRI trials, failed exposure therapy), underwent a single high-dose psilocybin session (0.3 mg/kg) in a supported setting, followed by a structured 12-week integration protocol. This case study documents the 18-month follow-up period.

The psilocybin session produced a Type 2 ego dissolution experience (boundary dissolution), during which the client reported encountering and 'speaking with' a figure he identified as a deceased comrade. The client described a release of survivor's guilt that had been refractory to 12 years of conventional therapy. In the weeks following the session, the client's CAPS-5 score dropped from 52 (severe) to 24 (moderate), and at 18-month follow-up was 18 (subclinical).

The integration phase was critical. The client adopted a daily meditation practice, joined a veterans' integration circle, and resumed a relationship with his estranged children. At 18 months, he reported: 'The medicine didn't fix me. It showed me what was true, and then I had to build a life around what I saw.' This statement captures the essential clinical point: the psychedelic experience is not the intervention. The life built in its wake is the intervention. The medicine is the catalyst, not the cure.